Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

BACKGROUND: Bladder transitional cell carcinoma (BTCC) is the fourth most frequent neoplasia in men, clinically characterized by high recurrent rates and poor prognosis. Availability of urinary tumor biomarkers represents a convenient alternative for early detection and disease surveillance because...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongjie, Li, Changying, Wu, Huili, Zhang, Ting, Wang, Jin, Wang, Shixin, Chang, Jiwu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089778/
https://www.ncbi.nlm.nih.gov/pubmed/21496341
http://dx.doi.org/10.1186/1477-5956-9-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089778/
https://www.ncbi.nlm.nih.gov/pubmed/21496341
http://dx.doi.org/10.1186/1477-5956-9-21

Ejemplares similares